Search research articles
Contact Us
Filters
Showing results (61-70 of 383) with videos related to
Page
of 39
Sort By:
Journal of Cachexia, Sarcopenia and Muscle
|
April 20, 2022
Treating sarcopenia: the LACE trial
Andrew L Clark, Alexandra A I Abel
Lancet (London, England)
|
August 31, 2012
Heart failure--does it matter whether LVEF is reduced?
John G F Cleland, Andrew L Clark
Journal of Cardiac Failure
|
March 6, 2012
Beta-blockers and weight change in patients with chronic heart failure
Ben W J Boxall, Andrew L Clark
International Journal of General Medicine
|
November 1, 2022
Optimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges
Joseph J Cuthbert, Pierpaolo Pellicori, Andrew L Clark
International Journal of Cardiology
|
October 12, 2011
Is "pacemaker syndrome" a patho-physiological entity or a measure of quality of life?
Verah Harper, Simon D Thackray, Andrew L Clark
International Journal of Cardiology
|
April 10, 2012
Body mass index is related to the perception of exertional breathlessness in patients presenting with dyspnoea of unknown origin
Lee Ingle, John G Cleland, Andrew L Clark
Therapeutics and Clinical Risk Management
|
August 28, 2020
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
Joseph J Cuthbert, Pierpaolo Pellicori, Andrew L Clark
Cardiovascular Therapeutics
|
May 24, 2011
Influence of sex on treatment and outcome in chronic heart failure
Lutz Frankenstein, Andrew L Clark, Jorge P Ribeiro
BMJ (Clinical Research Ed.)
|
February 8, 2011
Does home oxygen benefit people with chronic heart failure?
Andrew L Clark, Miriam J Johnson, Iain Squire
Biomed Research International
|
May 7, 2014
The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure
Lee Ingle, John G Cleland, Andrew L Clark
Page
of 39
Search research articles
Search
Showing results (61-70 of 383) with videos related to
Sort By:
Page
of 39
Journal of Cachexia, Sarcopenia and Muscle
|
April 20, 2022
Treating sarcopenia: the LACE trial
Andrew L Clark, Alexandra A I Abel
Lancet (London, England)
|
August 31, 2012
Heart failure--does it matter whether LVEF is reduced?
John G F Cleland, Andrew L Clark
Journal of Cardiac Failure
|
March 6, 2012
Beta-blockers and weight change in patients with chronic heart failure
Ben W J Boxall, Andrew L Clark
International Journal of General Medicine
|
November 1, 2022
Optimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges
Joseph J Cuthbert, Pierpaolo Pellicori, Andrew L Clark
International Journal of Cardiology
|
October 12, 2011
Is "pacemaker syndrome" a patho-physiological entity or a measure of quality of life?
Verah Harper, Simon D Thackray, Andrew L Clark
International Journal of Cardiology
|
April 10, 2012
Body mass index is related to the perception of exertional breathlessness in patients presenting with dyspnoea of unknown origin
Lee Ingle, John G Cleland, Andrew L Clark
Therapeutics and Clinical Risk Management
|
August 28, 2020
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
Joseph J Cuthbert, Pierpaolo Pellicori, Andrew L Clark
Cardiovascular Therapeutics
|
May 24, 2011
Influence of sex on treatment and outcome in chronic heart failure
Lutz Frankenstein, Andrew L Clark, Jorge P Ribeiro
BMJ (Clinical Research Ed.)
|
February 8, 2011
Does home oxygen benefit people with chronic heart failure?
Andrew L Clark, Miriam J Johnson, Iain Squire
Biomed Research International
|
May 7, 2014
The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure
Lee Ingle, John G Cleland, Andrew L Clark
Page
of 39